Terumo (OTCMKTS:TRUMY) Corporation is a global medical technology company specializing in the development, manufacturing and distribution of a broad range of medical devices and supplies. The company operates through key segments that include Cardiac & Vascular, General Hospital, Blood Management and Diabetes Care. Its product portfolio encompasses vascular intervention solutions, heart-lung bypass systems, infusion pumps, catheter devices and blood collection and processing equipment, catering to hospitals, clinics and laboratory settings worldwide.
Founded in 1921 as a producer of precision thermometers by Dr. Kitasato Shibasaburo, Terumo has grown from its early roots in temperature measurement into a diversified medtech leader. Over the decades, the company has expanded its expertise through strategic R&D investments, acquisitions and partnerships, broadening its capabilities in minimally invasive therapies, automated blood processing and wearable glucose monitoring systems.
Terumo’s innovation footprint is supported by research and development centers and manufacturing facilities across Asia, North America and Europe. This global network enables the company to adapt its offerings to regional healthcare needs, collaborate with leading medical institutions and accelerate the commercialization of new technologies. Key products, such as coated stents, vascular closure devices and advanced infusion sets, serve a wide spectrum of therapeutic areas including cardiology, oncology and critical care.
Headquartered in Tokyo, Japan, Terumo is overseen by a management team led by the President and Chief Executive Officer, supported by a board of directors and executive officers. Under this leadership, the company continues to pursue growth through innovation, operational excellence and expansion into emerging healthcare markets, reinforcing its mission to contribute to society by saving and improving lives.
